Industry Insights

1. Trends And Benefits Of Lean Manufacturing In Pharmaceutical Injectable Facilities 8/4/2025

   The pharmaceutical injectable manufacturing sector is experiencing unprecedented transformation through lean manufacturing adoption. This analysis examines current implementation trends, productivity impacts, and quality integration strategies based on data from leading pharmaceutical organizations.

2. Targeted Modalities: Trends, Challenges, CDMO Considerations 8/11/2025

   Targeted modalities are designed to bind specifically to receptors or biological targets, ensuring a more directed and effective treatment while reducing systemic exposure and unintended side-effects.

3. Strategies To Enhance Efficiency In mAb Bioprocess Development 8/16/2025

   Advanced computational methods coupled with bioinformatics can be used to navigate the complexities of bioprocessing by anticipating challenges before they arise.

4. The Fruits Of Synthetic Biology 11/22/2022

   Can cell and gene therapies be programmed with sophisticated behaviors, to sense, make decisions, and treat important diseases effectively? Synthetic gene circuits may hold the key.

5. The Right Polymers For Your Modified Release Multiparticulate Capsule 10/9/2023

   Pharma companies aiming to tech transfer or scale-up modified release formulations often encounter hurdles when the formulation is not robust. Review how to select the right polymers and ensure you have a robust formulation strategy.

6. When Does GMP Matter In Non-GMP Settings? 4/5/2024

   Would you ever need to follow GMP standards in workspaces where GMP is not required or possible? This article digs into why, when, and how to follow the principles of GMP.

7. The High Requirements Placed On Pharmaceutical Labeling Solutions 8/18/2025

   Regulators are implementing new rules to combat counterfeit medicines. Learn how serialization, tamper-evident seals, and track-and-trace solutions protect products and patients from risk.

8. A Functional History Of Process Validation, Part 1 – A Weak Foundation 8/7/2020

   This article is the first of a two-part series that describes the origins of process validation to explain the underlying concepts necessary to control the advanced bioprocess manufacturing technologies required to make the next generations of biopharmaceutical therapies.

9. The Potential And Future Of Cell Therapy 4/22/2021

   While the field has made laudable progress in developing novel biomolecules that can be used to control cell function (e.g. mRNA, DNA, CRISPR, siRNA, proteins, peptides, etc.), very little progress has been made on reliably delivering these materials to a cell and enabling robust engineering of cell function without significantly impairing cell health. 

10. Don't Miss These 2025–2026 EMA IDMP Compliance Deadlines For Product Management Services 5/22/2025

    The EMA's Product Management Services will serve as a comprehensive database for consistent identification of medicines internationally. One deadline is quickly approaching on May 31. Are you ready?